Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

uniQure N.V.

Present follow-up data from AMT-130 Phase I/II trials

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
28 Feb 2024
Due
30 Jun 2024
Checked
1 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Up to three years of follow-up data to be presented in mid-2024”

What we found

Evidence strength A What the grades mean

The company committed to presenting up to three years of follow-up data by mid-2024, but only presented up to 24 months of data in July 2024, delaying the three-year data presentation.

  • A
    uniQure N.V. 10-Q filed 2024-08-01 Regulatory filing · published 1 Aug 2024 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 23e28b609f9e
    “On July 9, 2024, we announced updated interim clinical data including up to 24 months of follow-up data from 29 treated patients” ✓ confirmed on the page
  • A
    uniQure N.V. 10-Q filed 2025-07-29 Regulatory filing · published 29 Jul 2025 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint c4b6831ede5c
    “In the third quarter of 2025, we expect to present 3-year follow-up data from the ongoing Phase I/II studies of AMT-130” ✓ confirmed on the page

Market reaction: the shares moved +5.0% against the S&P 500 over the three sessions around the disclosure (31 Jul 2024 to 5 Aug 2024). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Present
Deliverable
AMT-130 follow-up data
In the company’s control
High
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-QURE-001860 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.